Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 651.90

+1.2%

12:03 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (327)	11/10/1999 12:23:00 AM
From: Miljenko Zuanic	Read Replies (1) of 3557

Is Somitomo so reach to throw money in the hole without bottom? Total $58 M. From 3Q 10Q: <<In connection with Regeneron's agreement to collaborate with Sumitomo Pharmaceuticals in the research and development of BDNF in Japan, Sumitomo Pharmaceuticals paid the Company $25.0 million through December 1997. The Company also received a $5.0 million research progress payment from Sumitomo Pharmaceuticals (reduced by $0.5 million of Japanese withholding tax) in August 1998. In addition, Sumitomo Pharmaceuticals has paid the Company $27.6 million through September 30, 1999 in connection with supplying BDNF for preclinical and clinical use. Regeneron has not supplied any BDNF to Sumitomo Pharmaceuticals in 1999, but expects to resume supplying BDNF in the first quarter of 2000.>> And, is Vogelos so INSANE that he do not know where else invest (throw?) his gain from MRK than into REGN stock? Something is wrong here???

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next